Immunocore Holdings (IMCR) PT Raised to $85 at Oppenheimer; 'promise of PRAME remains a focal point'
Tweet Send to a Friend
Oppenheimer analyst Justin Kim raised the price target on Immunocore Holdings (NASDAQ: IMCR) to $85.00 (from $75.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
